To hear about similar clinical trials, please enter your email below
Trial Title:
Communication Issues in Patient and Provider Discussions of Immunotherapy
NCT ID:
NCT05873608
Condition:
Hematopoietic and Lymphoid System Neoplasm
Malignant Solid Neoplasm
Conditions: Official terms:
Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Non-Randomized
Intervention model:
Single Group Assignment
Intervention model description:
For aim 4, each participant is assigned to watch a video and comprehension is tested
using a pre and post method
Primary purpose:
Other
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
Educational video
Description:
Testing an educational video
Arm group label:
Aim 4 tests an educational video
Intervention type:
Other
Intervention name:
Interview
Description:
Participate in interview
Arm group label:
Interview
Intervention type:
Other
Intervention name:
Observation
Description:
Undergo observation
Arm group label:
Interview
Other name:
Inspection
Other name:
Visual Inspection
Summary:
This trials studies communication issues in patient and provider discussions about
immunotherapy. The goal of this study is to describe where patients have heard about
immunotherapy, what the participants understand about it, how physicians and other
healthcare workers describe immunotherapy, and how educational videos may support patient
knowledge about immunotherapy.
Detailed description:
PRIMARY OBJECTIVES:
I. To identify misestimations about the risks and benefits of immunotherapy resulting
from media hype or other sources and assess if these misestimations persist post-provider
conversation about immunotherapy.
II. To qualitatively describe patient reported misunderstandings and to assess patient
understanding of technical terms and metaphors used in the immunotherapy conversation.
III. To identify provider and patient preferences for information to be communicated
about immunotherapy.
IV. Develop videos that describe immunotherapy and test their efficacy in improving
understanding using pre and post methodology.
OUTLINE:
Patients and their providers undergo observation during a conversation about
immunotherapy. Then participate in an interview over 20 minutes. Understanding of
educational videos is then tested.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- AIMS 1-3: All patients and providers who may have a discussion about immunotherapy
at the Winship Cancer Institute
- AIM 4: Any cancer patient
Gender:
All
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Emory University Hospital/Winship Cancer Institute
Address:
City:
Atlanta
Zip:
30322
Country:
United States
Status:
Recruiting
Contact:
Last name:
Rebecca D. Pentz, PhD
Phone:
404-778-5694
Email:
rpentz@emory.edu
Contact backup:
Last name:
Margie Dixon
Phone:
404-778-4379
Email:
mddixon@emory.edu
Investigator:
Last name:
Rebecca D. Pentz, PhD
Email:
Principal Investigator
Facility:
Name:
Atlanta VA Medical Center
Address:
City:
Decatur
Zip:
30033
Country:
United States
Status:
Recruiting
Contact:
Last name:
Wayne B. Harris, MD
Phone:
404-728-7680
Email:
Wayne.Harris@va.gov
Contact backup:
Last name:
Margie Dixon
Phone:
404-778-4379
Email:
mddixon@emory.edu
Investigator:
Last name:
Wayne B. Harris, MD
Email:
Principal Investigator
Start date:
October 6, 2016
Completion date:
August 1, 2025
Lead sponsor:
Agency:
Emory University
Agency class:
Other
Collaborator:
Agency:
National Cancer Institute (NCI)
Agency class:
NIH
Source:
Emory University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05873608
